Cytomorphologic and molecular characterization of spindle cell carcinoid tumors of the lung

Rachelle P. Mendoza,Emily Symes,Peng Wang,Cole Miller,Stephanie C. Thompson,Tatjana Antic,Anna Biernacka

DOI: https://doi.org/10.1002/cncy.22886

2024-07-20

Cancer Cytopathology

Abstract:Background Spindle cell carcinoid tumor (SCCT) is a rare variant of lung carcinoid tumor consisting predominantly or exclusively of spindle cells. To the authors' knowledge, this is the first study to date investigating the molecular characteristics of SCCTs. Methods Eighty‐five carcinoid tumors initially diagnosed by fine‐needle aspiration over a period of 10 years were reviewed. The final diagnostic classification was based on resection specimens. Six SCCTs were identified and characterized based on cytomorphology, and immunohistochemical and molecular features. Results Most patients with SCCT were Caucasian (100.0%), women (83.3%), asymptomatic (66.7%), and nonsmokers (83.3%). The median age at diagnosis was 78.0 years (range, 58.2–80.3 years). A higher proportion of patients who had SCCT were diagnosed with distant metastasis. The smears were cellular and demonstrated clean backgrounds without necrosis or mitotic activity. SCCTs comprised of bipolar‐to‐elongated cells with finely granular chromatin, inconspicuous nucleoli, scant cytoplasm, and minimal atypia or pleomorphism. The tumor cells sometimes appeared boomerang‐shaped and might mimic granulomas or blood vessels. SCCTs showed strong expression for pan‐cytokeratin, synaptophysin, chromogranin, and CD56, with weak TTF‐1 and a very low Ki‐67 proliferation index. All SCCTs had low tumor mutational burden and were microsatellite‐stable. One case showed multiple whole‐gene losses in chromosome 11, whereas another harbored duplication in ARID1A. Two cases demonstrated gains in chromosomes 17, one of which also showed gains in chromosome 18. None had a single nucleotide mutation. Conclusions SCCT is a rare subset of lung carcinoid tumors. These tumors harbor unique cytologic, prognostic, and molecular features that may have significant diagnostic and clinical implications.

oncology,pathology